Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00823069 · ClinicalTrials.gov registry record · NA
Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose
A NA study of Nasolabial Folds, sponsored by Medicis Global Service Corporation.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 3
- Study locations
NCT00823069 is a NA study of Nasolabial Folds that has completed, run by Medicis Global Service Corporation. The registered enrollment target is 60 participants, above the 52-participant average among 4 other Nasolabial Folds trials with a reported enrollment target (15% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT00823069, a NA study of Nasolabial Folds, has completed, sponsored by Medicis Global Service Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
Safety study that compares Perlane to Perlane with Lidocaine while correcting wrinkles in the area around your nose.
Conditions Studied
Interventions
- DEVICE Perlane and Perlane-L
Study Locations (3)
Florida
- - Coral Gables
Maryland
- - Hunt Valley
New York
- - Mount Cisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00823069
The ClinicalTrials.gov registry entry for NCT00823069 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 52-participant average among 4 other Nasolabial Folds trials with a reported enrollment target (15% higher). The listed sponsor is Medicis Global Service Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nasolabial Folds appearing as the primary indexed condition, and to 1 intervention - of which Perlane and Perlane-L is the first listed.
NCT00823069 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Maryland, New York.
Frequently Asked Questions
What is clinical trial NCT00823069 about?
NCT00823069 is a clinical study titled "Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose". Safety study that compares Perlane to Perlane with Lidocaine while correcting wrinkles in the area around your nose.
What is the current status of trial NCT00823069?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2009-01. Estimated completion is 2009-04.
What conditions does trial NCT00823069 study?
This clinical trial studies the following conditions: Nasolabial Folds.
What interventions are being tested in trial NCT00823069?
The interventions under investigation include: Perlane and Perlane-L (DEVICE).
Who is sponsoring clinical trial NCT00823069?
This trial is sponsored by Medicis Global Service Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00823069 being conducted?
This trial has 3 study locations across Florida, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nasolabial Folds
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Effectiveness of ELLANSÉ®-S Dermal Filler in the Treatment of Nasolabial Folds
RECRUITING · NA
-
Pilot Evaluation of Platelet Rich Fibrin Matrix (PRFM) for the Correction of Nasolabial Folds
COMPLETED · Phase 1
-
Evaluation of Pain With Lidocaine-Mixed Radiesse® Injectable Dermal Filler
COMPLETED · Phase 4
-
Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.